Cognitive and Physical Recovery After Hip Fracture in Frail Patients Using Digital Rehabilitation Technology
FEWF
Cognitive and Motor Recovery in Frail Patients With Hip Fracture: Effectiveness of Digital Technology-Assisted Rehabilitation and Analysis of Biomolecular Mechanisms
1 other identifier
interventional
30
1 country
2
Brief Summary
The aim of this study is to evaluate whether integrating a technology-based rehabilitation approach with conventional therapies in the rehabilitation of patients with proximal femoral fracture may be advantageous compared with conventional therapy alone. Specifically, the objective is to assess whether the addition of technology-assisted rehabilitation can improve cognitive function, in addition to motor function and overall abilities, compared with conventional rehabilitation alone. Furthermore, the study intends to explore the feasibility of implementing technology-assisted rehabilitation as a stable and routine component of everyday clinical practice, also considering the perspective of healthcare professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedStudy Start
First participant enrolled
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
March 13, 2026
January 1, 2026
5 months
January 13, 2026
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Changes in serum BDNF levels
Difference in serum brain-derived neurotrophic factor (BDNF) levels between baseline and the end of the rehabilitative treatment, assessed to evaluate biomolecular changes associated with neuroplasticity.
Baseline and within 3 days after completion of the rehabilitative treatment
Change in Timed Up and Go test
Difference in functional mobility, balance, and gait performance assessed using the Timed Up and Go test between baseline and end of rehabilitative treatment.
Baseline and within 3 days after completion of the rehabilitative treatment
Change in Timed Up and Go Dual Task test
Difference in cognitive-motor dual-task performance assessed using the Timed Up and Go Dual Task test between baseline and end of rehabilitative treatment.
Baseline and within 3 days after completion of the rehabilitative treatment
Secondary Outcomes (6)
Change in the Harris Hip Score (HHS)
Baseline and within 3 days after completion of the rehabilitative treatment
Change in the modified Barthel Index
Baseline and within 3 days after completion of the rehabilitative treatment
Change in pain intensity measured by the Numeric Rating Scale (NRS)
Baseline and within 3 days after completion of the rehabilitative treatment
Change in quality of life measured by the SF-36
Baseline and within 3 days after completion of the rehabilitative treatment
Analysis of the rs6265 polymorphism (Val66Met mutation) of the BDNF gen
Baseline
- +1 more secondary outcomes
Study Arms (2)
Conventional Rehabilitation
ACTIVE COMPARATORPatients receive a standard inpatient conventional rehabilitation program including joint mobilization, postural re-education, muscle strengthening, and gait training with assistive devices.
Technology-Assisted Integrated Rehabilitation
EXPERIMENTALPatients receive an integrated rehabilitation program combining sensor-based technology-assisted training (1/3 of daily sessions) with conventional rehabilitation (2/3 of daily sessions).
Interventions
The conventional rehabilitation programme includes assisted and facilitated joint mobilization exercises to improve range of motion; exercises for postural readaptation of the trunk to the upright position; isometric exercises; and gait training using a 4-wheeled walker or forearm crutches (Canadian crutches), aimed at improving walking ability and achieving an appropriate recovery of the gait pattern.
The technology/robotic group will perform one-third (1/3) of the daily rehabilitation using technology-assisted devices and two-thirds (2/3) using conventional rehabilitation. In addition to the conventional rehabilitation described below, the treatment will include technology-assisted rehabilitation consisting of facilitated active joint mobilization exercises with visual and auditory feedback, aimed at stimulating motor and cognitive functions, as well as gait training.
Eligibility Criteria
You may qualify if:
- Age between 65 and 89 years
- Patients who have undergone one of the following surgical treatments specifically for proximal femur fracture including Total hip arthroplasty (total hip replacement), Partial hip arthroplasty (hemiarthroplasty), Intramedullary nailing
- Time since surgery not exceeding 15 days
- Clinical stability
- Patients admitted to the rehabilitation wards of the centers involved in the study and therefore eligible for rehabilitative therapy.
You may not qualify if:
- Age \> 90 years
- Age \< 65 years
- Refusal to sign the informed consent form
- Behavioral or cognitive disorders limiting compliance with the rehabilitative treatment
- Presence of mechanical instability of the implanted surgical device
- Clinical instability (e.g., sepsis, severe anemia, cardiorespiratory failure) or pre-existing comorbidities affecting ambulation (neurological diseases or chronic pre-existing disabilities)
- Concomitant presence of other fractures that prevent the possibility of carrying out a rehabilitative treatment
- Severe visual impairments not correctable with lenses that prevent the patient from performing the treatment using digital tools
- Pre-existing motor disability prior to the femur fracture due to other systemic diseases (e.g., advanced-stage neurodegenerative diseases, severe heart failure)
- Conditions contraindicating the use of sensors (pacemaker, epilepsy, skin lesions, open wounds, and severe allergies in areas of contact with the devices).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
COT - Cure Ortopediche Traumatologiche
Messina, Italy, 98124, Italy
Fondazione Don Carlo Gnocchi - Centro Santa Maria della Provvidenza
Roma, Italy, 00166, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Rehabilitation Department
Study Record Dates
First Submitted
January 13, 2026
First Posted
February 6, 2026
Study Start
February 9, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
March 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share